US Sleep-Wake Disorder Market
US Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Industry Overview
US sleep-wake disorder market was valued at $7.6 billion in 2025 and is projected to reach $13.8 billion by 2035, growing at a CAGR of 6.2% from 2026 to 2035. The US market continues to witness steady expansion supported by increasing clinical attention toward neurological and sleep-related health conditions. Greater availability of advanced diagnostic technologies across hospitals and specialty care centers has strengthened treatment accessibility. In addition, rising healthcare expenditure and broader insurance coverage for sleep-related therapies are encouraging patient adoption of long-term care solutions. Pharmaceutical innovation and the introduction of technologically enhanced therapeutic devices are further contributing to industry development. The market is also benefiting from growing collaboration between healthcare providers, research institutions, and medical device manufacturers. Continuous investment in digital health platforms and home-based monitoring systems is expected to support sustained market progress over the coming years.
Market Dynamics
Expansion of Home-Based Sleep Monitoring Technologies
The US market is experiencing increasing adoption of home-based diagnostic and monitoring solutions designed to improve patient convenience and reduce dependency on in-clinic testing procedures. Healthcare providers are incorporating wearable technologies, remote monitoring platforms, and digital sleep assessment tools into routine patient management practices. This transition is supporting earlier identification of sleep-related conditions while improving long-term treatment adherence. Technological advancements in connected healthcare devices are also enabling real-time data collection and physician oversight. In addition, consumer preference for personalized healthcare solutions is accelerating demand for portable and easy-to-use systems. The growing integration of telehealth services with sleep diagnostics continues to strengthen this market trend across the country.
Rising Focus on Innovative Therapeutic Developments
Market participants in the US are increasingly investing in advanced therapeutic approaches aimed at improving clinical outcomes and patient comfort. Pharmaceutical companies and medical device manufacturers are expanding research activities focused on targeted therapies, non-invasive treatment systems, and next-generation respiratory support technologies. Continuous product development efforts are contributing to broader treatment availability for diverse patient populations. Regulatory support for innovative healthcare solutions is also encouraging commercialization activities within the sector. Furthermore, healthcare institutions are strengthening partnerships with technology providers to improve treatment efficiency and patient engagement. These developments are contributing to a more competitive and innovation-driven market environment in the United States.
Market Segmentation
- Based on the disorder type, the market is segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm sleep-wake disorders, parasomnias, dyssomnias, and others.
- Based on the treatment type, the market is segmented into pharmacological therapy, behavioral therapy, light therapy, device-based therapy, and others.
- Based on the diagnosis & management approach, the market is segmented into polysomnography & sleep studies, actigraphy-based monitoring, clinical evaluation & screening tools, and remote/digital sleep monitoring solutions.
- Based on the application, the market is segmented into hospitals, home care settings, and others.
Insomnia Segment to Lead the Market with the Largest Share
The insomnia segment continues to gain prominence due to the increasing prevalence of chronic stress, irregular lifestyles, and rising mental health concerns among the population. Demand is further strengthened by growing awareness regarding early diagnosis and long-term management of persistent sleep disturbances. Pharmaceutical therapies and cognitive behavioral approaches remain widely adopted, with companies focusing on safer and more targeted formulations. Leading industry participants are also investing in digital therapeutics and app-based sleep coaching solutions to enhance patient engagement. Recent developments highlight a shift toward non-addictive treatment options supported by clinical research. The segment is expected to maintain steady growth driven by continuous innovation and expanding patient awareness.
Device-Based Therapy: A Key Segment in Market Growth
The device-based therapy segment is witnessing significant expansion driven by increasing adoption of advanced respiratory support systems and wearable sleep management devices. The rising incidence of sleep apnea and related respiratory disorders has contributed to stronger demand for continuous positive airway pressure technologies and next-generation alternatives. Key manufacturers are focusing on improving device comfort, portability, and connectivity features to enhance patient compliance. Integration of smart sensors and remote monitoring capabilities is further reshaping treatment delivery models. Strategic collaborations between medical device companies and healthcare providers are accelerating product adoption across clinical and home care environments. The segment continues to evolve with a strong emphasis on precision-based and patient-centric therapeutic solutions.
Market Players Outlook
The major companies operating in the US sleep-wake disorder market include ResMed Inc., Inspire Medical Systems Inc., Jazz Pharmaceuticals plc, Harmony Biosciences Holdings Inc., and Eli Lilly and Company, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In April 2026, ProSomnus received FDA Class II 510(k) clearance for its RPMO? OSA Device, a combined oral appliance and multi-night physiological monitoring system designed for obstructive sleep apnea management. The system is positioned as a “theragnostic” solution integrating treatment and diagnostic capability in a single platform. This expands ProSomnus’ US portfolio into connected, precision-based sleep therapy solutions aimed at reducing dependence on CPAP-only care pathways.
- In February 2026, REMSleep completed the full commercial rollout of its DeltaWave nasal pillow system across the United States, following expanded FDA 510(k) clearance that broadened its use across multiple care settings, including hospitals and institutional environments. The company also secured Medicare coding approvals, enabling broader reimbursement access and accelerating market penetration among durable medical equipment providers. This expansion represents a significant scaling phase from limited deployment to full US commercialization.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Key companies operating in the US sleep-wake disorder market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- US Sleep-Wake Disorder Market Sales Analysis – Disorder Type | Treatment Type | Diagnosis & Management Approach | Application ($ Million)
- Sleep-Wake Disorder Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Sleep-Wake Disorder Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Sleep-Wake Disorder Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For US Sleep-Wake Disorder Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For US Sleep-Wake Disorder Market: Impact Analysis
- Market Opportunities
- Opportunities For US Sleep-Wake Disorder Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Sleep-Wake Disorder Market Revenue and Share by Manufacturers
- Sleep-Wake Disorder Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Eli Lilly and Company
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Harmony Biosciences Holdings Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Inspire Medical Systems Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Jazz Pharmaceuticals plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- ResMed Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Eli Lilly and Company
- Key Company Analysis
- US Sleep-Wake Disorder Market Sales Analysis by Disorder Type ($ Million)
- Insomnia
- Hypersomnia
- Sleep Apnea
- Circadian Rhythm Sleep-Wake Disorders
- Parasomnias
- Dyssomnias
- Others
- US Sleep-Wake Disorder Market Sales Analysis by Treatment Type ($ Million)
- Pharmacological Therapy
- Behavioral Therapy
- Light Therapy
- Device-Based Therapy
- Others
- US Sleep-Wake Disorder Market Sales Analysis by Diagnosis & Management Approach ($ Million)
- Polysomnography & Sleep Studies
- Actigraphy-Based Monitoring
- Clinical Evaluation & Screening Tools
- Remote / Digital Sleep Monitoring Solutions
- US Sleep-Wake Disorder Market Sales Analysis by Application ($ Million)
- Hospitals
- Home Care Settings
- Others
- Company Profiles
- Apnimed Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BMC Medical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ceribell Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Compumedics Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Drive DeVilbiss Healthcare LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fisher and Paykel Healthcare Corp. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Harmony Biosciences Holdings Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Inspire Medical Systems Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Itamar Medical Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jazz Pharmaceuticals plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Masimo Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck and Co. Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Natus Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Neurocrine Biosciences Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nihon Kohden Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Oventus Medical Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ResMed Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sleep Number Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SomnoMed Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Takeda Pharmaceutical Company Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Wesper Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Apnimed Inc.
1. US Sleep-Wake Disorder Market Research and Analysis by Disorder Type, 2025-2035 ($ Million)
2. US Insomnia Disorder Market Research and Analysis, 2025-2035 ($ Million)
3. US Hypersomnia Disorder Market Research and Analysis, 2025-2035 ($ Million)
4. US Sleep Apnea Disorder Market Research and Analysis, 2025-2035 ($ Million)
5. US Circadian Rhythm Sleep-Wake Disorder Market Research and Analysis, 2025-2035 ($ Million)
6. US Parasomnias Disorder Market Research and Analysis, 2025-2035 ($ Million)
7. US Dyssomnias Disorder Market Research and Analysis, 2025-2035 ($ Million)
8. US Other Sleep-Wake Disorder Market Research and Analysis, 2025-2035 ($ Million)
9. US Sleep-Wake Disorder Market Research and Analysis by Treatment Type, 2025-2035 ($ Million)
10. US Sleep-Wake Disorder by Pharmacological Therapy Market Research and Analysis, 2025-2035 ($ Million)
11. US Sleep-Wake Disorder by Behavioral Therapy Market Research and Analysis, 2025-2035 ($ Million)
12. US Sleep-Wake Disorder by Light Therapy Market Research and Analysis, 2025-2035 ($ Million)
13. US Sleep-Wake Disorder by Device-Based Therapy Market Research and Analysis, 2025-2035 ($ Million)
14. US Sleep-Wake Disorder by Other Treatment Type Market Research and Analysis, 2025-2035 ($ Million)
15. US Sleep-Wake Disorder Market Research and Analysis by Diagnosis & Management Approach, 2025-2035 ($ Million)
16. US Polysomnography & Sleep Studies Market Research and Analysis, 2025-2035 ($ Million)
17. US Actigraphy-Based Monitoring Market Research and Analysis, 2025-2035 ($ Million)
18. US Clinical Evaluation & Screening Tools Market Research and Analysis, 2025-2035 ($ Million)
19. US Remote / Digital Sleep Monitoring Solutions Market Research and Analysis, 2025-2035 ($ Million)
20. US Sleep-Wake Disorder Market Research and Analysis by Application, 2025-2035 ($ Million)
21. US Sleep-Wake Disorder for Hospitals Market Research and Analysis, 2025-2035 ($ Million)
22. US Sleep-Wake Disorder for Home Care Settings Market Research and Analysis, 2025-2035 ($ Million)
23. US Sleep-Wake Disorder for Other Application Market Research and Analysis, 2025-2035 ($ Million)
1. US Sleep-Wake Disorder Market Share by Disorder Type, 2025 Vs 2035 (%)
2. US Insomnia Disorder Market Share, 2025 Vs 2035 (%)
3. US Hypersomnia Disorder Market Share, 2025 Vs 2035 (%)
4. US Sleep Apnea Disorder Market Share, 2025 Vs 2035 (%)
5. US Circadian Rhythm Sleep-Wake Disorder Market Share, 2025 Vs 2035 (%)
6. US Parasomnias Disorder Market Share, 2025 Vs 2035 (%)
7. US Dyssomnias Disorder Market Share, 2025 Vs 2035 (%)
8. US Other Sleep-Wake Disorder Market Share, 2025 Vs 2035 (%)
9. US Sleep-Wake Disorder Market Share by Treatment Type, 2025 Vs 2035 (%)
10. US Sleep-Wake Disorder by Pharmacological Therapy Market Share, 2025 Vs 2035 (%)
11. US Sleep-Wake Disorder by Behavioral Therapy Market Share, 2025 Vs 2035 (%)
12. US Sleep-Wake Disorder by Light Therapy Market Share, 2025 Vs 2035 (%)
13. US Sleep-Wake Disorder by Device-Based Therapy Market Share, 2025 Vs 2035 (%)
14. US Sleep-Wake Disorder by Other Treatment Type Market Share, 2025 Vs 2035 (%)
15. US Sleep-Wake Disorder Market Share by Diagnosis & Management Approach, 2025 Vs 2035 (%)
16. US Polysomnography & Sleep Studies Market Share, 2025 Vs 2035 (%)
17. US Actigraphy-Based Monitoring Market Share, 2025 Vs 2035 (%)
18. US Clinical Evaluation & Screening Tools Market Share, 2025 Vs 2035 (%)
19. US Remote / Digital Sleep Monitoring Solutions Market Share, 2025 Vs 2035 (%)
20. US Sleep-Wake Disorder Market Share by Application, 2025 Vs 2035 (%)
21. US Sleep-Wake Disorder for Hospitals Market Share, 2025 Vs 2035 (%)
22. US Sleep-Wake Disorder for Home Care Settings Market Share, 2025 Vs 2035 (%)
23. US Sleep-Wake Disorder for Other Application Market Share, 2025 Vs 2035 (%)
- Printable version
- No restriction to number of users within the company
